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Background: Dandruff is an irritative disease of the scalp in which shedding of 
dead tissue from the scalp with itching sensation is the cardinal feature. It can be 
correlated to Darunaka. The cardinal symptoms of the disease Darunaka are 
Kandu (Itching), Keshachyuti (falling of hair), Swapa (abnormalities of touch 
sensation), Rookshata (roughness or dryness of the skin) and Twaksphutana 
(breaking or cracking of the skin). Yogaratnakara has mentioned the application 
of Gunjataila (i.e., Gunja, Bhringaraj, Tilataila) in the treatment of Darunaka. In 
the current dermatological practice there is no effective modern remedy for 
dandruff. Hence the present study is undertaken to find effective and safe 
alternative to conventional topical anti-dandruff agents. Objectives: To compare 
the effects of Shiroabhyanga with Gunjataila and Tila Taila in the management 
Darunaka. Materials and methods: This study was Randomized, open labelled, 
non-controlled, comparative clinical study. In Group A, Gujataila shiroabhyanga 
and in Group-B Tilataila Shiroabhyanga was done for thirty days, daily once in 
the morning, after the completion of treatment, all the patients were advised to 
attend the O.P.D for two months at regular interval of fifteen days for the follow 
up study to assess the post effects of treatment. Results: Group A showed 
complete remission in 30%, marked improvement in 30%, moderate 30% and 
10% mild relief. In patients of Group B only 30% moderate relief and 10% mild 
relief from the Darunaka is noticed and 60% of the patients found no relief. 
Conclusion: Gunjataila shiroabhyanga has higher significant effect in pacifying 
the symptoms of Darunaka and marked reduction in clinical symptoms was well 
appreciated within one month duration. There was no topical and systemic 
adverse drug effects noted at the end of the study.  
INTRODUCTION
Dandruff is an irritative disease of the scalp1 in 
which shedding of dead tissue from the scalp with itching 
sensation is the cardinal feature. It can be correlated to 
Darunaka2 which is one among the Kapalagata Vyaadhi3. 
The causative factors of Darunaka are not practicing 
shiroabhyanga4, Improper cleaning, sleeping during day 
time, Night vigil, Exposure to dust, hot weather5 etc. Now 
a days, due to increased pollution, busy mechanical life 
schedule application of impure oils to head, etc. causing 
high incidence of Darunaka with cardinal symptoms like 
Kandu (Itching), Rookshata (roughness or dryness of the 
skin), Twaksphutana (breaking or cracking of the skin) 
and Keshachyuti (falling of hair)6, due to the vitiation of 
Vata and Kapha dosha7. Till now there is no definite 
cause and solution for this disease. So there is a need to 
find a safe and effective remedy in the treatment of 
Darunaka.  
Yogaratnakara has mentioned the application of 
Gunjataila8 (i.e., Gunja, Bhringaraj, Tilataila) in the 
treatment of Darunaka. The drugs of the yoga are easily 
available, economical and effective. Therefore, a clinical 
research work is proposed entitled – “A Clinical Study on 
Gunja Taila Shiroabhyanga in the Management of 
Darunaka” to contribute a solution for the Darunaka. The 
treatment principles mentioned are Siravyadha 
(Raktamokshana), Shiroabhyanga, Nasya, Shirolepana, 
Shiroprakshalana and Shirobasti9 which is considered as 
Sadya Vyadhi.10 
OBJECTIVES  
 To compare the effects of Shiroabhyanga with 
Gunjataila and Tila Taila in the management Darunaka 
MATERIALS AND METHODS 
Study Design: Randomized, open labelled, non-
controlled, comparative clinical study. 
Source of Data: The patients who fulfil the Diagnostic 
criteria for Darunaka were selected randomly from the 
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OPD and IPD of Shalakyatantra, S.D.M. Ayurvedic College 
and Hospital, Hassan. 
Study Population: Patients were selected from the 
Hassan, Karnataka. 
Study Sample: Patients of Darunaka attending the OPD 
and IPD of Shalakya Tantra, S.D.M. Ayurvedic College and 
Hospital.  
Sample Size: 20 
Study Setting: This study was carried on Darunaka 
patients at S.D.M. Ayurvedic College and Hospital, Hassan 
from year 2004 to 2006. 
Trial Drugs 
1. Gujataila shiroabhyanga in Group A. 
2. Tilataila Shiroabhyanga in Group B. 
Collection of Drugs: All the raw materials required for 
the preparation of Gunjataila were procured and 
purchased from the Department of Dravyaguna, 
S.D.M.C.A. Hassan.  
Method of preparation of Gunjataila: The trial 
medicine was prepared in the department of Rasa 
shastra and Bhishajya kalpana as per the Taila11 was 
prepared as per Snehapaka vidhi. 
Ingredients: 
Table 1: Showing the Drugs used in the preparation 
of the Gunjataila 
S.No. Drugs Quantity 
01. Gunjabeeja 1 part. (to prepare Kalka) 
02. Tilataila 4parts 
03. Bhrungaraja 16 parts (Swarasa) 
Diagnostic Criteria: 
1) Itching at scalp (Kandu) 
2) Diffuse hair fall (Keshachyuti) 
3) Roughness of scalp (Rukshata) 
4) Scaling of scalp skin (Twaksphutana) 
Inclusion criteria 
 The patients presenting with classical features of 
Darunaka as mentioned in diagnostic criteria were 
selected irrespective of Sex and Socio economic 
status. 
Exclusion Criteria 
 Associated with other dermatological conditions 
such as psoriasis etc.  
 Patients having Chronic infectious diseases 
(tuberculosis, leprosy etc.) and metabolic diseases 
(DM, hypothyroidism etc.) 
 Other types of Kapala rogas 
Investigations 
1. Blood for Hb%, TC, DC, ESR. 
2. Urine for sugar, albumin. 
Grouping: Patients were divided into 2 groups. i.e., 
Group A and Group B. 
Group A – Gunjataila shiroabhyanga was applied for 
thirty days, once daily, in the morning. 
Group B –Tilataila shiroabhyanga was applied for 
thirty days, once daily, in the morning. 
 
Procedure of Shiroabhyanga 
 The Shiroabhyanga is one among the 
Bahrparimarjana chikitsa12 which is done in following 
methods13: Patient is made to sit in comfortable position 
by using Sukoshna Gunjataila and Tilataila 
shiroabhyanga14 done for respectively A & B group for 
the duration of 5 Minutes. It is carried out by using tip of 
the fingers gently massage over the Scalp. 
Follow up study: After the completion of treatment, all 
the patients were advised to attend the O.P.D for two 
months at regular interval of fifteen days for the follow 
up study to assess the post effects of treatment. 
Criteria for Assessment of Treatment 
Assessment of treatment were made before and after the 
treatment based on, 
1. Kesha bhoomi Rookshata 
2. Kandu 
3. Twaksphutana 
4. Kesha chyuti 
Gradation Index 
Showing Gradation Index for assessment criteria 
Kesha bhoom Rookshata  
Absent : 0 
Negligible : 1 
Without discomfort on scalp : 2 
With discomfort on scalp : 3 
Kandu  
Absent : 0 
Occasionally : 1 
Frequently : 2 
Constantly : 3 
Twak sphutana (fine flakes)  
Absent : 0 
Visible inside the hair : 1 
Visible over the hair : 2 
Spreaded over the shoulder  3 
Keshachyuti  
Absent : 0 
Occasionally : 1 
Moderate loss : 2 
Maximum loss : 3 
Overall effect of Therapy 
Severity of Darunaka: For assessing the severity of 
Darunaka in each patient the above adopted scores were 
grouped and assessed as follows. 
Showing overall effect of therapy 
Grade Score 
Absent 0 0 
Mild 1 1 – 4 Score 
Moderate 2 5 – 8 Score 
Severe 3 > 8 Score 
Criteria for Assessment of Overall Effects 
Overall effect of the therapy was assessed in 
terms of complete remission, marked improvement, 
moderate improvement, and mild improvement and 
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unchanged is observed by adopting the following criteria. 
Complete Remission: 100% relief in Chief complaints 
and no recurrence during follow up study were 
considered as complete remission  
Marked Improvement: 75 - 100% improvement in chief 
complaints is recorded as marked improvement  
Moderate Improvement: 50 - 75% improvement in 
chief complaints is recorded as moderate improvement. 
Mild Improvement: 25-50% improvement in chief 
complaints is considered as mild improvement 
Unchanged: Less than 25% reduction in chief 
complaints or recurrence of the symptoms to the similar 
extent of severity is noted as recurrence 
Statistical analysis of the result 
The results having p value less than < 0.05 is 
considered as statistically significant in this study. 
OBSERVATIONS 
General Observation: Twenty patients of Darunaka 
were registered for this clinical study. They were divided 
into two groups, Gunjataila Shiroabhyanga group (Group 
A) and Tilataila Shiroabhyanga group (Group B) for the 
purpose of comparative assessment of treatment. Age 
wise distribution of patients showed that 07 patients (35 
%) were in the age group of 10 – 19 yrs, 10 patients (50 
%) were in the age group of 20 – 29 years, 02 patients 
(10 %) were in the age group of 30 – 39 years and 1 
patient (05 %) was between the age of group 40-49yrs. 
Out of 20 cases, the incidence of Darunaka is observed 08 
(40 %) in the male and 12 (60 %) in the female patients. 
Socio-economic status wise distribution of patients 
showed that 11 patients (55%) were belonged to lower 
class, 07 patients were (35%) to middle class and 02 
patients were (10 %) to upper class. Out of 20 patients, 
05 patients (25 %) were of Vata kapha, 07 patients (35 
%) were of Vata pitta prakruti and 08 patients (40 %) 
were of Kapha pitta. 
Table 2: Showing Incidences of Symptoms in Patients 
Symptoms Group A Group B Total 
No. of pt’s % No. of pt’s % No. of pt’s % 
Kandu 10 100 10 100 20 100 
Rookshata 10 100 10 100 20 100 
Twaksphutana 10 100 10 100 20 100 
Keshachyuti 09 90 08 80 17 85 
Table 3: Showing the ‘t’ test results in reduction of severity of Kandu in Group A group and Group B group after 
treatment and during follow up 




Df ‘t’ ‘p’ 
BT AT Red % 
Group A AT 2.3 0.6 1.7 73 0.48 0.15 9 11.13 <0.001 
FUI 2.3 0.5 1.8 78 0.42 0.13 9 13.50 <0.001 
FU2 2.3 0.6 1.7 73 0.48 0.15 9 11.13 <0.001 
Group B AT 2.5 2.1 0.4 16 0.52 0.16 9 2.45 <0.05 
FU1 2.5 2.2 0.3 12 0.48 0.15 9 1.96 <0.10 
Fu2 2.5 2.3 0.2 8 0.42 0.13 9 1.50 <0.20 
Table 4: Showing the ‘t’ test results in reduction of severity of Rookshata in Group A group and Group B group 
after treatment and during follow up 




Df ‘t’ ‘p’ 
BT AT Red % 
Group A AT 2.4 0.7 1.7 70 0.48 0.15 9 11.13 <0.001 
FUI 2.4 0.6 1.8 75 0.42 0.13 9 13.50 <0.001 
FU2 2.4 0.7 1.7 70 0.48 0.15 9 11.13 <0.001 
Group B AT 2.4 1.8 0.5 25 0.71 0.22 9 2.29 <0.05 
FU1 2.4 2 0.4 16 0.52 0.22 9 2.45 <0.05 
Fu2 2.4 2.1 0.3 12 0.48 0.15 9 1.96 <0.10 
Table 5: Showing the ‘t’ test results in reduction of severity of Twaksphutana in Group A group and Group B 
group after treatment and during follow up 




Df ‘t’ ‘p’ 
BT AT Red % 
Group A AT 1.7 0.4 1.3 76 0.48 0.15 9 8.51 <0.001 
FUI 1.7 0.3 1.4 82 0.52 0.16 9 8.57 <0.001 
FU2 1.7 0.4 1.3 76 0.48 0.15 9 8.51 <0.001 
Group B AT 1.8 1.2 0.6 33 0.70 0.22 9 2.71 <0.025 
FU1 1.8 1.3 0.5 27 0.71 0.22 9 2.24 <0.05 
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Table 6: Showing the ‘t’ test results in reduction of severity of Keshachyuti in Group A group and Group B group 
after treatment and during follow up 




Df ‘t’ ‘p’ 
BT AT Red % 
Group A AT 1.4 0.5 0.9 64 0.32 0.10 9 9.00 <0.001 
FUI 1.4 0.4 1 71 0.47 0.15 9 6.71 <0.001 
FU2 1.4 0.5 0.9 64 0.32 0.10 9 9.00 <0.001 
Group B AT 1.4 0.8 0.6 42 0.70 0.22 9 2.71 <0.025 
FU1 1.4 0.8 0.6 42 0.70 0.22 9 2.71 <0.025 
Fu2 1.4 0.9 0.5 35 0.71 0.22 9 2.24 <0.05 
Table 7: Showing the ‘t’ test results in reduction of severity of Darunaka in Group A group and Group B group 
after treatment and during follow up 




Df ‘t’ ‘p’ 
BT AT Red % 
Group A AT 2.4 0.8 1.6 66 0.52 0.16 9 9.80 <0.001 
FUI 2.4 0.7 1.7 70 0.48 0.15 9 11.13 <0.001 
FU2 2.4 0.8 1.6 66 0.52 0.16 9 9.80 <0.001 
Group B AT 2.4 2 0.4 16 0.52 0.16 9 2.45 <0.05 
FU1 2.4 2.1 0.3 12 0.48 0.15 9 1.96 <0.10 
Fu2 2.4 2.2 0.2 08 0.42 0.13 9 1.50 <0.20 
Table 8: Showing the percentage of improvement in the symptoms of Darunaka in Group A and Group B groups 
after treatment and during follow ups 
Percentage of Relief Group A Group B 
 AT FU1 FU2 AT FU1 FU2 
Kandu 73 78 73 16 12 08 
Rookshata 70 75 70 25 16 12 
Twaksphutana 76 82 76 33 27 22 
Kesha chyuti 64 71 64 42 42 35 
Table 9: Showing over all percentage of improvement in the patients of Group A and Group B groups 
Overall %age Group A  Group B 
Relief AT FU1 FU2 FU3 FU4 AT FU1 FU2 FU3 FU4 
Complete Relief  30 30 30 30 30 00 00 00 00 00 
Marked Relief 30 30 30 30 30 00 00 00 00 00 
Moderate Relief 30 40 40 10 30 30 30 20 20 20 
Mild Relief 10 00 00 00 10 10 10 10 10 00 
No Relief 00 00 00 00 00 60 60 70 70 80 
DISCUSSION 
Darunaka is generally correlated to Dandruff or 
Pytiriasis capitis, it resembles more accurately with the 
signs and symptoms of dry variety of Pytiriasis capitis. 
Few of the significantly resembling factors are Twak 
Sphutana (scales are dry, fine, white and fall freely on 
shoulders), Rookshata (hair are dry and fine), Kandu 
(mild itching). But hair fall has not been directly 
mentioned in the modern classics; Even then we can 
consider Kasha chyuti as a reason of Rookshata of hairs. 
Effect on Kandu: Severity of Kandu is significantly 
reduced after treatment in Gunjataila group. The 
reduction of Kandu within the groups was Group A 73% 
and Group B 16%. The effects of Group A group was 
significant at level of p<0.001. It indicates that, Gunjataila 
Shiroabhyanga is better than Tilataila Shiroabhyanga. It 
is due to the effect of Gunja and Bhrungaraja present in 
the Gunjataila 
Effect on Rookshata: Severity of Rookshata of Kapala 
pradesha is significantly reduced after treatment in 
Group A group with 70% of efficacy and Group B group 
showed only 25% efficacy. The effect of Group A group 
was significant at level of p<0.001. This data indicates 
that Gunjataila shiroabhyanga is more effective in 
reducing severity of Rookshata. 
Effect on Shedding of scales: Severity of shedding of 
Scales is significantly reduced after treatment Group A 
group with 76% of efficacy whereas Group B group 
showed only 33% of efficacy in reducing the shedding of 
scales. The effect of Group A group was significant at the 
level of p<0.001. This data indicates that Gunjataila is 
more effective in reducing severity of shedding of Scales 
than Tilataila. 
Effect on Keshachyuti: Severity of Falling of hairs is 
significantly reduced after treatment in Group A group 
with 64% of efficacy and Group B group showed a lesser 
efficacy of 42%. The effect of Group A group was 
significant at level of p<0.001. This data indicates that 
Gunjataila Shiroabhyanga is more effective in reducing 
severity of hair fall. 
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Discussion on Overall Effects of the Therapy 
 Consideration of overall effect of therapies after 
one month of treatment showed that in Group A group 
complete remission was found in 30% (6 pt’s), marked 
improvement was found in 30% (6 pt’s), moderate 30% 
(6 pt’s) and 10% (2 pt’s) mild relief. In patients of Group 
B group only 30% (6 pt’s) moderate relief and 10% (2 
pt’s) mild relief from the Darunaka is noticed and 60% 
(12 pt’s) of the patients found no relief. 
Follow Up 
 On the basis of the above results it can be 
concluded that Gunjataila shiroabhyanga not only 
provide cure to the patients of Darunaka, but it also 
prevents its recurrence. In the second follow up the 
recurrence in one patient of Group A might have 
occurred due to indulgence in Nidana again and not 
following the advice. 
Comparison of Effects of Therapies 
Gunjataila Shiroabhyanga: Shiroabhyanga with 
Gunjataila provided better relief in all symptoms of 
Darunaka especially in Kandu, Rookshata, Twaksphutana 
and Keshachyuti. 
Tilataila Shiroabhyanga: Shiroabhyanga with Tilataila 
provided moderate relief in all symptoms of Darunaka 
but 60% of the patients didn’t show any relief. The above 
discussions infer that in Group A group the effect of the 
drug is higher than Group B group. Hence from the above 
results it may be abstracted that Shiroabhyanga with 
Gunjataila provided better overall effect to the patients 
of Darunaka with highly significant statistical values than 
Shiroabhyanga with Tilataila. 
CONCLUSION 
Group A group showed complete remission in 
30%, marked improvement in 30%, moderate 30% and 
10% mild relief. In patients of Group B group only 30% 
moderate relief and 10% mild relief from the Darunaka 
is noticed and 60% of the patients found no relief. 
Gunjataila shiroabhyanga has higher significant effect in 
pacifying the symptoms of Darunaka and marked 
reduction in clinical symptoms was well appreciated 
within one month duration. There was no topical and 
systemic adverse drug effects noted at the end of the 
study.  
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